- $37 million of series 2013A hospital revenue refunding bonds
- $161.7 million of series 2012A hospital revenue refunding bonds
- $177.2 million of series 2006 hospital revenue bonds
The rating upgrade was based on a number of factors, including TGH’s strong liquidity, improved profitability and solid market position in a competitive area.
The outlook is stable.
More articles on finance:
Fitch affirms Wright Memorial Hospital’s bonds
Moody’s affirms Novant Health’s bond ratings
Moody’s revises Anderson Hospital’s outlook to positive
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
